Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 7/20 | 0.36 |
| ▸ | FGF1 | P05230 | 2/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.34 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.30 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.30 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.30 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.30 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19213283 | 0.90 | SSTR1 (0.36) | LGALS8FGF1TNFSSTR1SSTR2 | |
| SCHEMBL16556418 | 0.88 | LGALS8 (0.43) | LGALS8FGF1TNFGAA | |
| SCHEMBL15281691 | 0.88 | FGF1 (0.40) | LGALS8FGF1TNFGAA | |
| SCHEMBL12082990 | 0.84 | FGF1 (0.37) | LGALS8FGF1 | |
| SCHEMBL18519128 | 0.84 | TNF (0.36) | LGALS8FGF1TNF | |
| SCHEMBL13539943 | 0.77 | LGALS8 (0.44) | LGALS8FGF1TNF | |
| SCHEMBL13626265 | 0.74 | CA2 (0.49) | LGALS8GAA | |
| SCHEMBL19213281 | 0.74 | LGALS8 (0.38) | LGALS8GAA | |
| SCHEMBL12219328 | 0.74 | LGALS8 (0.38) | LGALS8GAA | |
| SCHEMBL13051478 | 0.73 | CA1 (0.36) | LGALS8FGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170042775-A1 | COSMETIC COMPOSITION | L'OREAL (FR) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170042775-A1 | COSMETIC COMPOSITION | CUTA, DSG1, H1-0 | LGALS8 2655/4885FGF1 1469/4885TNF 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.